BIO-RAD LAB-A (BUWA BE) stock market data APIs
€272.2061
0(0%)
as of October 21, 2025
Try our APIs with
free plan!
BIO-RAD LAB-A Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BUWA.BE.
Prev. Close
272.2061
Open
272.2061
High
272.2061
Low
272.2061
52 wk Range
187.6-351.8
Market Cap
19 783 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BIO-RAD LAB-A data using free add-ons & libraries
Get BIO-RAD LAB-A Fundamental Data
BIO-RAD LAB-A Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIO-RAD LAB-A News
New
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
HERCULES, Calif., October 16, 2025--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its finan...
Aurora Cannabis (ACB) Soars 6.2%: Is Further Upside Left in the Stock?
Aurora Cannabis Inc. (ACB) shares rallied 6.2% in the last trading session to close at $6.17. This move can be attributable to notable volume with a higher number of shares being traded than in a typi...
Multi-Plex Immunoassays Market to Reach US$ 6.90 Billion by 2033 as Precision Medicine and Biomarker Discovery Fuel Global Adoption | DataM Intelligence
AUSTIN, Texas and TOKYO, Oct. 7, 2025 /PRNewswire/ -- The Multi-Plex Immunoassays Market is entering a new era of growth as clinical diagnostics, drug discovery, and personalized medicine increasingl...
Bio-Rad Laboratories (BIO): Is the Current Valuation Justified After Recent Share Price Uptick?
Bio-Rad Laboratories (BIO) has seen its stock edge upward over the past week, catching some attention among investors. Shares closed at $297.95, reflecting modest gains that contrast with longer-term ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
